Drug Type AAV based gene therapy |
Synonyms AAV9-GCase |
Target |
Mechanism GBA stimulants(Beta-glucocerebrosidase stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | GB | 07 May 2024 |